Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 2 Results

Intervention Indication Therapeutic Area Year Actions
Tiragolumab with atezolizumab for oesophageal squamous cell cancer Atezolizumab (Tecentriq; MPDL3280A) , Tiragolumab (RG-6058; MTIG7192A) Oesophageal squamous cell carcinoma Head and Neck Cancer 2023 View  |  Download
Tislelizumab with chemotherapy for previously
untreated advanced oesophageal squamous cell
Tislelizumab (BGB-A317; BGBA-317) Oesophageal squamous cell carcinoma Gastrointestinal Cancer 2022 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications